Stay updated on Amivantamab & Lazertinib Combo in EGFR+ NSCLC Clinical Trial

Sign up to get notified when there's something new on the Amivantamab & Lazertinib Combo in EGFR+ NSCLC Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Amivantamab & Lazertinib Combo in EGFR+ NSCLC Clinical Trial page

  1. Check
    6 days ago
    No Change Detected
  2. Check
    13 days ago
    Change Detected
    Summary
    The study record now shows recruitment is closed to new participants, and new recruitment sites (e.g., Hunan Cancer hospital 1 and University College Hospital) along with updated navigation items were added to aid readers in understanding how to join and read the study.
    Difference
    0.3%
    Check dated 2026-06-10T14:41:35.000Z thumbnail image
  3. Check
    21 days ago
    Change Detected
    Summary
    Revision updated from v3.5.4 to v3.5.5, indicating a new version of the study documentation has been issued for the record.
    Difference
    0.0%
    Check dated 2026-06-03T08:10:18.000Z thumbnail image
  4. Check
    35 days ago
    Change Detected
    Summary
    A new revision entry was added: Revision: v3.5.4, replacing the prior v3.5.3. This indicates a routine update to the Study Details page.
    Difference
    0.0%
    Check dated 2026-05-19T23:57:58.000Z thumbnail image
  5. Check
    42 days ago
    Change Detected
    Summary
    The update history now includes May 2026 entries (2026-05-08, 2026-05-07, 2026-05), while April 2026 entries (2026-04-22, 2026-04-09, 2026-04) were removed. These entries document when the page was updated, not changes to the study content.
    Difference
    0.1%
    Check dated 2026-05-12T20:51:56.000Z thumbnail image
  6. Check
    57 days ago
    Change Detected
    Summary
    Two new Chinese study sites were added: Hunan Cancer Hospital Chest Tumor Internal Medicine dept. II in Changsha and Beijing Cancer Hospital Chest Tumor Internal Medicine dept. II in Beijing, bringing total locations to 249 and updating the record to revision v3.5.3.
    Difference
    0.2%
    Check dated 2026-04-28T08:04:38.000Z thumbnail image
  7. Check
    64 days ago
    Change Detected
    Summary
    The page footer revision was updated from v3.5.0 to v3.5.2.
    Difference
    0.0%
    Check dated 2026-04-21T01:34:49.000Z thumbnail image

Stay in the know with updates to Amivantamab & Lazertinib Combo in EGFR+ NSCLC Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Amivantamab & Lazertinib Combo in EGFR+ NSCLC Clinical Trial page.